Centers

Weccome Centre for Anti-Infectives Research

Therapeutic Accelerator Program (TAP)

UCSC Chemical Screening Center

WCAIR brings together the Drug Discovery Unit (DDU) , the Mode of Action group and the Parasitology research groups. With the daily interactions of these groups, parasitology and drug discovery can work together in synergy. This empowers us to create...
Read more

Test

Read more

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more

Partnerships

Events

Jobs

Yale to Partner with Gilead to Further Cancer Research

Yale and Gilead have entered into a multi-year research collaboration to develop new treatments against cancer. Gilead will provide $40million in funding for research and other infrastructure support for the initial four years. The agreement can...

 
View all

UCB To Fund "Mining the Human Microbiome" Project at Harvard

UCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of three years to immunologists at Harvard to study the...

 
View all

Sanofi and Weill Cornell Medical College to Discover New Drus to Treat Tuberculosis

Sanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment of tuberculosis and increase effectiveness of...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All